Equols (S-equol / equol) has evolved from a "single active" concept into an industrialized ingredient-and-delivery ecosystem, where commercial success is driven by purity tiering and dosage-form engineering rather than academic differentiation. In practice, Equols demand is anchored in women's health and functional wellness, and the key buying criteria are consistent assay (>=99% vs <99%), batch-to-batch reproducibility, and scalable conversion/formulation capabilities (Tablet vs Capsule). In select jurisdictions, litigation outcomes can effectively restrict the sale of specific equol-related products, making freedom-to-operate and compliant commercialization an integral part of the business model.
Market expansion is increasingly value-led, with pricing and mix upgrades outpacing pure volume growth. Global sales rose from 5,526 kg in 2021 to 6,758 kg in 2026E, while revenue increased from USD 8.69m to USD 12.95m over the same period. In 2025, the market delivered 6,357 kg and USD 10.88m, implying an average price of ~USD 1,711/kg. Over 2026-2032F, revenue CAGR is ~8.7% versus volume CAGR of ~5.1%, indicating that Equols monetization is structurally supported by premiumization and formulation upgrades.
Supplier structure is concentrated and increasingly stratified by price band. In 2025, the Top 5 producers (Daicel, Ningbo Inno Pharmchem, Shenghe Everything (Shanghai) Biotechnology, Wuhan Finetech Industry, Shanghai Banglin Biotechnology) captured ~60.8% of volume and ~74.8% of revenue. Daicel alone accounted for ~33.8% of volume but ~58.5% of revenue, reflecting a pronounced premium position. Regionally, production is dominated by Japan and China (~75% combined share in 2025), while demand is centered in Asia-Pacific (~57% share). By category, >=99% products represent ~69.9% of 2025 volume and ~74.1% of revenue; by application, Tablets remain the base (~68.3% volume share) but Capsules are growing faster and carry a higher price per kg, reshaping the value pool for Equols.
The global Equols market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Equols market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2021-2032.
Market Segmentation
By Company
- Daicel
- Anthem Biosciences
- Ningbo Inno Pharmchem
- Shenghe Everything (Shanghai) Biotechnology
- Wuhan Finetech Industry
- Hubei Xinmingtai Chemical
- Shanghai Banglin Biotechnology
Segment by Type
Segment by Application
Major Region and Country
- North America
- Europe
- China
- Japan
- Other Regions
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales and revenue of Equols in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region.
Chapter 3: Detailed analysis of Equols manufacturers competitive landscape, sales, revenue, price, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Region anaylsis by company, by Type, by Application, sales, revenue, and price for each segment, and by customer
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Equols revenue, gross margin, and recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Sales channels analysis
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Table of Contents
1 Market Overview
- 1.1 Equols Product Scope
- 1.2 Equols by Type
- 1.2.1 Global Equols Sales by Type (2021 & 2025 & 2032)
- 1.2.2 >=99%
- 1.2.3 <99%
- 1.3 Equols by Application
- 1.3.1 Global Equols Sales Comparison by Application (2021 & 2025 & 2032)
- 1.3.2 Tablet
- 1.3.3 Capsule
- 1.4 Global Equols Market Estimates and Forecasts (2021-2032)
- 1.4.1 Global Equols Market Size in Value Growth Rate (2021-2032)
- 1.4.2 Global Equols Market Size in Volume Growth Rate (2021-2032)
- 1.4.3 Global Equols Price Trends (2021-2032)
- 1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
- 2.1 Global Equols Market Size by Region: 2021 VS 2025 VS 2032
- 2.2 Global Equols Retrospective Market Scenario by Region (2021-2026)
- 2.2.1 Global Equols Sales Market Share by Region (2021-2026)
- 2.2.2 Global Equols Revenue Market Share by Region (2021-2026)
- 2.3 Global Equols Market Estimates and Forecasts by Region (2027-2032)
- 2.3.1 Global Equols Sales Estimates and Forecasts by Region (2027-2032)
- 2.3.2 Global Equols Revenue Forecast by Region (2027-2032)
- 2.4 Major Region and Emerging Market Analysis
- 2.4.1 North America Equols Market Size and Prospective (2021-2032)
- 2.4.2 Europe Equols Market Size and Prospective (2021-2032)
- 2.4.3 China Equols Market Size and Prospective (2021-2032)
- 2.4.4 Japan Equols Market Size and Prospective (2021-2032)
- 2.4.5 India Equols Market Size and Prospective (2021-2032)
3 Global Market Size by Type
- 3.1 Global Equols Historic Market Review by Type (2021-2026)
- 3.1.1 Global Equols Sales by Type (2021-2026)
- 3.1.2 Global Equols Revenue by Type (2021-2026)
- 3.1.3 Global Equols Price by Type (2021-2026)
- 3.2 Global Equols Market Estimates and Forecasts by Type (2027-2032)
- 3.2.1 Global Equols Sales Forecast by Type (2027-2032)
- 3.2.2 Global Equols Revenue Forecast by Type (2027-2032)
- 3.2.3 Global Equols Price Forecast by Type (2027-2032)
4 Global Market Size by Application
- 4.1 Global Equols Historic Market Review by Application (2021-2026)
- 4.1.1 Global Equols Sales by Application (2021-2026)
- 4.1.2 Global Equols Revenue by Application (2021-2026)
- 4.1.3 Global Equols Price by Application (2021-2026)
- 4.2 Global Equols Market Estimates and Forecasts by Application (2027-2032)
- 4.2.1 Global Equols Sales Forecast by Application (2027-2032)
- 4.2.2 Global Equols Revenue Forecast by Application (2027-2032)
- 4.2.3 Global Equols Price Forecast by Application (2027-2032)
- 4.3 New Sources of Growth in Equols Application
5 Competition Landscape by Players
- 5.1 Global Equols Sales by Players (2021-2026)
- 5.2 Global Top Equols Players by Revenue (2021-2026)
- 5.3 Global Equols Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Equols as of 2025)
- 5.4 Global Equols Average Price by Company (2021-2026)
- 5.5 Global Key Manufacturers of Equols, Manufacturing Sites & Headquarters
- 5.6 Global Key Manufacturers of Equols, Product Type & Application
- 5.7 Global Key Manufacturers of Equols Founded Date
6 Region Analysis
- 6.1 China Market: Players, Segments, Downstream and Major Customers
- 6.1.1 China Equols Sales by Company
- 6.1.2 China Equols Sales Breakdown by Type (2021-2026)
- 6.1.3 China Equols Sales Breakdown by Application (2021-2026)
- 6.1.4 China Equols Major Customer
- 6.1.5 China Market Trend and Opportunities
- 6.2 Japan Market: Players, Segments, Downstream and Major Customers
- 6.2.1 Japan Equols Sales by Company
- 6.2.2 Japan Equols Sales Breakdown by Type (2021-2026)
- 6.2.3 Japan Equols Sales Breakdown by Application (2021-2026)
- 6.2.4 Japan Equols Major Customer
- 6.2.5 Japan Market Trend and Opportunities
- 6.3 India Market: Players, Segments, Downstream and Major Customers
- 6.3.1 India Equols Sales by Company
- 6.3.2 India Equols Sales Breakdown by Type (2021-2026)
- 6.3.3 India Equols Sales Breakdown by Application (2021-2026)
- 6.3.4 India Equols Major Customer
- 6.3.5 India Market Trend and Opportunities
7 Company Profiles and Key Figures
- 7.1 Daicel Corporation
- 7.1.1 Daicel Corporation Company Information
- 7.1.2 Daicel Corporation Business Overview
- 7.1.3 Daicel Corporation Equols Sales, Revenue and Gross Margin (2021-2026)
- 7.1.4 Daicel Corporation Equols Products Offered
- 7.1.5 Daicel Corporation Recent Development
- 7.2 Anthem Biosciences Private Limited.
- 7.2.1 Anthem Biosciences Private Limited. Company Information
- 7.2.2 Anthem Biosciences Private Limited. Business Overview
- 7.2.3 Anthem Biosciences Private Limited. Equols Sales, Revenue and Gross Margin (2021-2026)
- 7.2.4 Anthem Biosciences Private Limited. Equols Products Offered
- 7.3 Ningbo Inno Pharmchem
- 7.3.1 Ningbo Inno Pharmchem Company Information
- 7.3.2 Ningbo Inno Pharmchem Business Overview
- 7.3.3 Ningbo Inno Pharmchem Equols Sales, Revenue and Gross Margin (2021-2026)
- 7.3.4 Ningbo Inno Pharmchem Equols Products Offered
- 7.4 Shenghe Everything (Shanghai) Biotechnology
- 7.4.1 Shenghe Everything (Shanghai) Biotechnology Company Information
- 7.4.2 Shenghe Everything (Shanghai) Biotechnology Business Overview
- 7.4.3 Shenghe Everything (Shanghai) Biotechnology Equols Sales, Revenue and Gross Margin (2021-2026)
- 7.4.4 Shenghe Everything (Shanghai) Biotechnology Equols Products Offered
- 7.5 Wuhan Finetech Industry
- 7.5.1 Wuhan Finetech Industry Company Information
- 7.5.2 Wuhan Finetech Industry Business Overview
- 7.5.3 Wuhan Finetech Industry Equols Sales, Revenue and Gross Margin (2021-2026)
- 7.5.4 Wuhan Finetech Industry Equols Products Offered
- 7.6 Hubei Xinmingtai Chemical
- 7.6.1 Hubei Xinmingtai Chemical Company Information
- 7.6.2 Hubei Xinmingtai Chemical Business Overview
- 7.6.3 Hubei Xinmingtai Chemical Equols Sales, Revenue and Gross Margin (2021-2026)
- 7.6.4 Hubei Xinmingtai Chemical Equols Products Offered
- 7.7 Shanghai Banglin Biotechnology
- 7.7.1 Shanghai Banglin Biotechnology Company Information
- 7.7.2 Shanghai Banglin Biotechnology Business Overview
- 7.7.3 Shanghai Banglin Biotechnology Equols Sales, Revenue and Gross Margin (2021-2026)
- 7.7.4 Shanghai Banglin Biotechnology Equols Products Offered
8 Equols Manufacturing Cost Analysis
- 8.1 Equols Key Raw Materials Analysis
- 8.1.1 Key Raw Materials
- 8.1.2 Key Suppliers of Raw Materials
- 8.2 Proportion of Manufacturing Cost Structure
- 8.3 Manufacturing Process Analysis of Equols
- 8.4 Equols Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
- 9.1 Marketing Channel
- 9.2 Equols Distributors List
- 9.3 Equols Customers
- 9.3.1 OTSUKA Phamaceutical Co.Ltd.
10 Equols Market Dynamics
- 10.1 Equols Industry Trends
- 10.2 Equols Market Drivers
- 10.3 Equols Market Challenges
- 10.4 Equols Market Restraints
11 Research Findings and Conclusion
12 Appendix
- 12.1 Research Methodology
- 12.1.1 Methodology/Research Approach
- 12.1.2 Data Source
- 12.2 Author Details
- 12.3 Disclaimer